- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.59 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.2: 3 residues within 4Å:- Chain A: T.186, N.226, Y.230
No protein-ligand interaction detected (PLIP)NAG.3: 2 residues within 4Å:- Chain A: N.197, E.198
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:E.198
NAG.4: 1 residues within 4Å:- Chain A: N.207
No protein-ligand interaction detected (PLIP)NAG.5: 3 residues within 4Å:- Chain A: G.233, R.235, N.237
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.237
NAG.8: 3 residues within 4Å:- Chain C: T.186, N.226, Y.230
No protein-ligand interaction detected (PLIP)NAG.9: 2 residues within 4Å:- Chain C: N.197, E.198
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:E.198
NAG.10: 1 residues within 4Å:- Chain C: N.207
No protein-ligand interaction detected (PLIP)NAG.11: 3 residues within 4Å:- Chain C: G.233, R.235, N.237
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.237
NAG.14: 3 residues within 4Å:- Chain E: T.186, N.226, Y.230
No protein-ligand interaction detected (PLIP)NAG.15: 2 residues within 4Å:- Chain E: N.197, E.198
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:E.198
NAG.16: 1 residues within 4Å:- Chain E: N.207
No protein-ligand interaction detected (PLIP)NAG.17: 3 residues within 4Å:- Chain E: G.233, R.235, N.237
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.237
- 3 x 01: N-{3-[(1Z)-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1-phenylbut-1-en-2-yl]phenyl}-N'-[(3R)-oxolan-3-yl]sulfuric diamide
01.6: 15 residues within 4Å:- Chain A: R.33, V.35, G.36, L.37, E.69, A.70, G.71, L.155
- Chain B: L.14, Y.16, T.18, T.19, D.21, M.47, L.57
15 PLIP interactions:8 interactions with chain A, 7 interactions with chain B- Hydrophobic interactions: A:R.33, A:V.35, A:V.35, A:L.37, A:A.70, A:A.70, A:L.155, B:L.14, B:Y.16, B:Y.16, B:T.18, B:L.57
- Salt bridges: A:E.69, B:D.21
- Hydrogen bonds: B:Y.16
01.12: 15 residues within 4Å:- Chain C: R.33, V.35, G.36, L.37, E.69, A.70, G.71, L.155
- Chain D: L.14, Y.16, T.18, T.19, D.21, M.47, L.57
15 PLIP interactions:7 interactions with chain D, 8 interactions with chain C- Hydrophobic interactions: D:L.14, D:Y.16, D:Y.16, D:T.18, D:L.57, C:R.33, C:V.35, C:V.35, C:L.37, C:A.70, C:A.70, C:L.155
- Hydrogen bonds: D:Y.16
- Salt bridges: D:D.21, C:E.69
01.18: 15 residues within 4Å:- Chain E: R.33, V.35, G.36, L.37, E.69, A.70, G.71, L.155
- Chain F: L.14, Y.16, T.18, T.19, D.21, M.47, L.57
15 PLIP interactions:8 interactions with chain E, 7 interactions with chain F- Hydrophobic interactions: E:R.33, E:V.35, E:V.35, E:L.37, E:A.70, E:A.70, E:L.155, F:L.14, F:Y.16, F:Y.16, F:T.18, F:L.57
- Salt bridges: E:E.69, F:D.21
- Hydrogen bonds: F:Y.16
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dada, L. et al., SuFEx-enabled high-throughput medicinal chemistry for developing potent tamoxifen analogs as Ebola virus entry inhibitors. Front Immunol (2025)
- Release Date
- 2025-07-30
- Peptides
- Envelope glycoprotein: ACE
GP2: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.59 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x 01: N-{3-[(1Z)-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1-phenylbut-1-en-2-yl]phenyl}-N'-[(3R)-oxolan-3-yl]sulfuric diamide
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dada, L. et al., SuFEx-enabled high-throughput medicinal chemistry for developing potent tamoxifen analogs as Ebola virus entry inhibitors. Front Immunol (2025)
- Release Date
- 2025-07-30
- Peptides
- Envelope glycoprotein: ACE
GP2: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B